Global Brain Monitoring Market Report 2022: Favorable Government Regulations Regarding the Adoption of Brain Monitoring Devices to Accelerate Growth Moving Forward
August 05, 2022 04:48 ET
|
Research and Markets
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Brain Monitoring Market By Product Type, By End Use, By Application, and By Region" report has been added to ResearchAndMarkets.com's offering. The...
GTX Discusses the Future for Senior Healthcare
July 12, 2022 08:24 ET
|
GTX Corp
GPS SmartSole On aPlaceforMom list of Best GPS Tracking Devices for Seniors with Dementia LOS ANGELES CALIFORNIA, July 12, 2022 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO) (“the...
New Alzheimer's Treatment on Horizon as Dementia Reversed for First Time in Dogs
June 21, 2022 07:46 ET
|
Skin2Neuron Pty Ltd.
SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- With the once dominant amyloid hypothesis of Alzheimer's disease suffering yet another crushing blow this week, the field is desperate for a ray of hope....
The Global Dementia Drugs Market is Expected to Register Immense Growth at a CAGR of 8.42% by 2027 | DelveInsight
June 02, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, June 02, 2022 (GLOBE NEWSWIRE) -- The Global Dementia Drugs Market is Expected to Register Immense Growth at a CAGR of 8.42% by 2027 | DelveInsight The dementia drugs market is...
Alzheimer's Patient Advocates Launch Free Courses Promoting Brain Health
May 26, 2022 14:37 ET
|
UsAgainstAlzheimer's
Washington, D.C., May 26, 2022 (GLOBE NEWSWIRE) -- Today UsAgainstAlzheimer’s announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with...
Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight
March 07, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 07, 2022 (GLOBE NEWSWIRE) -- Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight With the increasing numbers of promising treatments...
Global Alzheimer's Disease Therapeutics & Diagnostics Market 2021-2028 - Emerging Novel Diagnostic Technologies Presents Lucrative Opportunities for Players
February 04, 2022 05:18 ET
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Therapeutics and Diagnostics Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
January 25, 2022 07:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Lui Franciosi To Assess the Safety and Efficacy of a New Dementia Treatment
January 05, 2022 16:00 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing and monitoring the safety and efficacy of the new...
LiveFreely Announces Apple Watch Version of 'BUDDY,' the Predictive AI-Driven Digital Health Assistant for Seniors and Their Loved Ones
December 22, 2021 09:00 ET
|
LiveFreely Inc
SAN JOSE, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- LiveFreely, Inc., a Silicon Valley digital health company that develops innovative technology to improve the health and well-being of seniors and...